Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
  • 首页
The 11th Asia Pharma R&D Leaders 2022

The 11th Asia Pharma R&D Leaders 2022

Time:August 26th-27th, 2022

AddressShanghai · China

ThemeClinical Value Oriented to Make the Real New Drug

The 11th Asia Pharma R&D Leaders (APRL) is a high-end strategic summit in Asia focusing on drug discovery and development. The 11th APRL 2022 will once again bring together top experts in new drug R&D from global multinational pharmaceutical companies, domestic and international biotechnology companies, scientific research institutes and other institutions.APRL 2022 will focus on clinical value-oriented and patient-centered drug development and innovation,work together to improve the efficiency of clinical development, accelerate the speed of new drug development to market, actively explore differentiated R&D strategies, promote the internationalization of innovative drug development, and connect global drug R&D Leaders, work together to overcome human medical problems and unmet clinical needs!

Conference Overview

【Event Highlight】

The 11th Asia Pharma R&D Leaders 2022

Hot Topics / Agenda

>>Oriented by Clinical Value: The Science Road of China's Drug Development and Regulatory

>>Globalization of New Drug Development: The Policies and Regulatory Environment of Overseas Drug Review and Approval

>>Strategies and Key Challenges for Early Research and Development of New Drugs

>>Source Innovation: Target Development and New Compound Screening

>>Global Clinical Cooperation: The Construction and Practice of International Multi-Center Clinical Strategy

>>Key Elements and Considerations of Innovative Drug Clinical Trial Design

>>Application of Translational Medicine in the Early Research of New Drugs

>>] From Chinese New to Global New: Construction of China's Pharmaceutical Innovation Ecosystem

>>Thoughts on Regulatory Registration and Risk Management under the Simultaneous Development of Global New Drugs

>>Experience Exchange: Dilemma of Global Clinical Trials and Practice Case Sharing

>>Analysis of the Key and Difficult Points in the Development of Bispecific Antibody Drugs

>>The Next 100 Billion Market: The Development of ADC Drugs

>>Strategy and Case Analysis of Small Molecule Drug Development

>>CMC Key Strategies and Considerations in the Development of New Small Molecule Drugs

>>Race of New Crown 'Specific Drugs': Progress and Breakthroughs in Research and Development of Neutralizing Antibody Therapeutic Drugs

>>The Pattern of Antibody Research and Development : Differentiated Development and Layout of Antibody Drugs

>>Discussion on the High-Quality Transformation Strategy of Innovative Drug Commercialization    

>>Competition in the Global Arena: Differentiated Strategy and Layout of Small Molecule Drug Research and Development

>>Strategy Sharing of Cell and Gene Therapy Product Process Development

>>Development Progress of China's mRNA COVID-19 Vaccine

>>Development and Innovative Exploration of New AAV Gene Therapy

>>The New Pattern and Trend of Investment and Mergers in China's Pharmaceutical Industry

>>Investment and Financing of Innovative Pharmaceutical Companies: Strategies and Considerations for Multi-Party Cooperation

>>Multinational Pharmaceutical Companies in China: Drug R&D Model and Innovation Ecosystem

>>Road to Industrialization: Analysis of Commercialization Strategy of Cell Therapy

>>Collaborative Innovation: Construction of External R&D Innovation Model and Case Sharing

Who should attend

The 11th Asia Pharma R&D Leaders 2022

Outstanding Past Speakers

The 11th Asia Pharma R&D Leaders 2022

The 11th Asia Pharma R&D Leaders 2022

The 11th Asia Pharma R&D Leaders 2022

Part of Previous Attending Companies

The 11th Asia Pharma R&D Leaders 2022

The 11th Asia Pharma R&D Leaders 2022

【Wonderful Moment

The 11th Asia Pharma R&D Leaders 2022

Event Organizer

The 11th Asia Pharma R&D Leaders 2022

The 11th Asia Pharma R&D Leaders 2022
Conference Organizer / Co-Organizer

The 11th Asia Pharma R&D Leaders 2022

Guidance / co-sponsor / support

The 11th Asia Pharma R&D Leaders 2022

  • Taicang Investment Promotion Bureau
Cooperative Media
Travel & Stay

For inquiries and media cooperation, please contact

Aili Li

Tel: (86 21) 6095 7201

E-mail: aili.li@shine-consultant.com